Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SLP
SLP logo

SLP News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

SLP News

Simulations Plus Under Investigation for Securities Violations

2d agoGlobenewswire

Investor Rights Law Firm Investigates Multiple Companies

3d agoPRnewswire

Halper Sadeh LLC Investigates Multiple Companies for Potential Violations

5d agoGlobenewswire

Monteverde Law Firm Investigates Multiple Mergers

5d agoGlobenewswire

Simulations Plus Partners with NVIDIA to Accelerate Drug Development

5d agoNewsfilter

Investor Rights Law Firm Investigates Multiple Companies

6d agoPRnewswire

Investigation Alerts for Multiple Company Mergers

6d agoGlobenewswire

Simulations Plus Under Investigation for Securities Violations

6d agoPRnewswire

SLP Events

06/23 13:00
Nvidia Launches BioNeMo Toolkit to Advance AI Research
Catch up on the top artificial intelligence news and commentary by Wall Street analysts on publicly traded companies in the space with this daily recap compiled by The Fly.TECH SELLOFF:Micronand Nvidiaare leading a broad tech selloff on Tuesday, as investors weigh concerns around AI spending levels and a more hawkish interest-rate backdrop. Traders appear increasingly focused on whether enormous capital spending commitments across AI infrastructure, data centers and chips can justify current valuations.NVIDIA/BIONEMO:Nvidia announced Nvidia BioNeMo Agent Toolkit, which provides domain-specific tools and skills for the agentic life sciences era. Including more than a decade's worth of Nvidia life sciences libraries, tools and open models, the toolkit enables AI agents, scientists and labs to work together by gathering evidence, reasoning across findings, running computational experiments and recommending the next best steps to accelerate discovery. "Frontier models are the brains. BioNeMo is the scientific toolbox. Together, they give AI agents the skills of a PhD research assistant and the speed of a supercomputer," said Jensen Huang, founder and CEO of Nvidia. "For the first time, researchers can build AI agents that understand scientific knowledge, use scientific tools and execute scientific workflows. This is a new way to do science - one that can dramatically accelerate discovery across biology, chemistry, genomics and medicine."NVIDIA/SIMULATIONSPLUS:Simulations Plusannounced it is building the agentic layer of Composer using the Nvidia BioNeMo Agent Toolkit. The initiative expands the companies' collaboration announced in May 2026, extending their work in GPU-accelerated simulation and AI-assisted modeling workflows into agentic drug development. Together, the companies are combining AI reasoning, scientific literature, validated computational engines, and scalable compute within a scientific workflow, they said.NVIDIA/PENGUIN:Penguin Solutionshas become an Nvidia AI Factory Specialized Partner, joining a select group of Nvidia Partner Network solution providers. Penguin achieved this invitation-only Nvidia AI Factory specialization by completing Nvidia's comprehensive training, maintaining the relevant competencies, meeting solution requirements, and bringing proven experience in designing, building, deploying, and operating full-stack, Nvidia-based AI factory infrastructure for enterprise and hyperscale customers.QUALCOMM/MODULAR:Qualcommis in advanced discussions to acquire Modular in a deal valuing the AI chip startup at roughly $4B, Bloomberg's Liana Baker and Ryan Gould report, citing people familiar with the matter. A transaction could be formally announced in the coming weeks, though a final agreement hasn't been reached yet, the authors note.IBM/OPENAI:IBMannounced it has joined the OpenAI Daybreak Cyber Partner Program, bringing frontier AI capabilities into security operations. Building on the recently announced Project Lightwell, as part of this effort IBM has launched a new application security service that uses the cyber capabilities of OpenAI's models to help organizations identify and validate software vulnerabilities. Through this program, IBM is working with OpenAI to apply advanced AI capabilities to be deployed defensively inside enterprise workflows.
06/23 09:30
Simulations Plus Partners with NVIDIA to Develop Drug Agentic Layer
Simulations Plus (SLP) announced it is building the agentic layer of Composer using the NVIDIA (NVDA) BioNeMo Agent Toolkit. The initiative expands the companies' collaboration announced in May 2026, extending their work in GPU-accelerated simulation and AI-assisted modeling workflows into agentic drug development. Together, the companies are combining AI reasoning, scientific literature, validated computational engines, and scalable compute within a scientific workflow.
06/18 07:30
Craig-Hallum Downgrades Simulations Plus to Hold with $18.50 Price Target
Craig-Hallum downgraded Simulations Plus to Hold from Buy with an $18.50 price target after the company entered into an agreement to be acquired by affiliates of Altaris for $18.50 per share.

SLP Monitor News

No data

No data

SLP Earnings Analysis

No Data

No Data

People Also Watch